2012
DOI: 10.1016/j.febslet.2012.07.024
|View full text |Cite
|
Sign up to set email alerts
|

Generating pluripotent stem cells: Differential epigenetic changes during cellular reprogramming

Abstract: Pluripotent stem cells hold enomous potential for therapuetic applications in tissue replacement therapy. Reprogramming somatic cells from a patient donor to generate pluripotent stem cells involves both ethical concerns inherent in the use of embryonic and oocyte-derived stem cells, as well as issues of histocompatibility. Among the various pluripotent stem cells, induced pluripotent stem cells (iPSC)—derived by ectopic expression of four reprogramming factors in donor somatic cells—are superior in terms of e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
28
0
1

Year Published

2013
2013
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 31 publications
(29 citation statements)
references
References 58 publications
0
28
0
1
Order By: Relevance
“…It is known that the reprogramming procedure to produce iPSCs leaves some residual epigenetic markers in the resulting iPSCs genome, which possibly interfere with the investigation of differential gene expression and epigenetic processes in brain disorders [10]. In addition, the procedures involved in generating iPSCs and deriving neurons from these are very time-consuming, costly and are not high-throughput.…”
Section: Pros and Cons: What Is Needed In The System?mentioning
confidence: 99%
“…It is known that the reprogramming procedure to produce iPSCs leaves some residual epigenetic markers in the resulting iPSCs genome, which possibly interfere with the investigation of differential gene expression and epigenetic processes in brain disorders [10]. In addition, the procedures involved in generating iPSCs and deriving neurons from these are very time-consuming, costly and are not high-throughput.…”
Section: Pros and Cons: What Is Needed In The System?mentioning
confidence: 99%
“…Moreover, iPSCs show genetic and epigenetic changes during reprogramming, especially tumorigenic mutations, which limit their differentiation potential, functionality, safety and potential clinical utility [120,121]. This is because the true replication model of iPSCs in vivo is unknown and the long-term influence of epigenetic changes introduced during iPS derivation and differentiation remains incompletely understood.…”
Section: Induced Pluripotent Stem Cellsmentioning
confidence: 99%
“…For instance, Oct4 and Nanog promoters are demethylated and histones H3 lysine 4 (K4) and lysine 27 mostly exhibit patterns of trimethylation [101,106,122] . However, reprogramming of NSCs into iPSCs is often incomplete and leaves epigenetic marks including DNA methylation, chromatin modification and transcriptional regulation in the resulting iPSC genome [123,124] known as epigenetic "memory". Partially reprogrammed cell lines are characterized by an absence of complete downregulation of the exogenous reprogramming factors and partial demethylation and reactivation of pluripotency genes [101,104] .…”
Section: Loss Of Epigenetic Memorymentioning
confidence: 99%